CKD-519 clinical trials
Also written CKD-519.
- studies test it
- 8
- open now
- 0
- in phase 3
- 0
- first study started
- 2014
How each study uses CKD-519 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
8 studies that test it; most in 2016 (3)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 0
Studies
Open first, then newest update. How each study uses CKD-519 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519CompletedPhase 1Chong Kun Dang PharmaceuticalNCT02753504Written as CKD-519
- Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male SubjectsCompletedPhase 1Chong Kun Dang PharmaceuticalNCT03175835Written as CKD-519 200 mg
- Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519CompletedPhase 1Chong Kun Dang PharmaceuticalNCT03210649Written as CKD-519
- Study to Investigate the Influence of CKD-519 on 24-h Ambulatory Blood Pressure in Healthy Adult VolunteersCompletedPhase 1Chong Kun Dang PharmaceuticalNCT02916901Written as CKD-519 200mg
- Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519CompletedPhase 1Chong Kun Dang PharmaceuticalNCT02894541Written as CKD-519 100mg
- Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.CompletedPhase 1Chong Kun Dang PharmaceuticalNCT02623868Written as CKD-519 50mg 2Tabs.
- Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)CompletedPhase 1Chong Kun Dang PharmaceuticalNCT02484482Written as CKD-519 200mg / Fasting, Standard Meal, High Fat Meal
- Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519CompletedPhase 1Chong Kun Dang PharmaceuticalNCT02156544Written as CKD-519